EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Value of Ultrasound for Detecting and Following Subclinical Interstitial Lung Disease in Systemic Sclerosis

Marwin Gutierrez, Chiara Bertolazzi, Edgar Zozoaga-Velazquez, Denise Clavijo-Cornejo iD

Tomography · 2024

DOI: 10.3390/tomography10040041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tomography, 2024. Verfasst von Marwin Gutierrez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center of Excellence in Rheumatic and Musculoskeletal Disorders, Mexico City 03530, Mexico. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Scleroderma, Systemic, Ultrasonography, Tomography, X-Ray Computed. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Interstitial lung disease (ILD) is a complication in patients with systemic sclerosis (SSc). Accurate strategies to identify its presence in early phases are essential. We conducted the study aiming to determine the validity of ultrasound (US) in detecting subclinical ILD in SSc, and to ascertain its potential in determining the disease progression.

Methods

133 patients without respiratory symptoms and 133 healthy controls were included. Borg scale, Rodnan skin score (RSS), auscultation, chest radiographs, and respiratory function tests (RFT) were performed. A rheumatologist performed the lung US. High-resolution CT (HRCT) was also performed. The patients were followed every 12 weeks for 48 weeks.

Results

A total of 79 of 133 patients (59.4%) showed US signs of ILD in contrast to healthy controls (4.8%) (p = 0.0001). Anti-centromere antibodies (p = 0.005) and RSS (p = 0.004) showed an association with ILD. A positive correlation was demonstrated between the US and HRCT findings (p = 0.001). The sensitivity and specificity of US in detecting ILD were 91.2% and 88.6%, respectively. In the follow-up, a total of 30 patients out of 79 (37.9%) who demonstrated US signs of ILD at baseline, showed changes in the ILD score by US.

Conclusions

US showed a high prevalence of subclinical ILD in SSc patients. It proved to be a valid, reliable, and feasible tool to detect ILD in SSc and to monitor disease progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung Diseases, InterstitialScleroderma, SystemicUltrasonographyTomography, X-Ray ComputedDisease ProgressionHumansFemaleMaleMiddle AgedAdultSensitivity and SpecificityLungAgedReproducibility of ResultsRespiratory Function Tests

Stichwörter der Autor:innen

interstitial lung diseasepulmonary ultrasoundsubclinicalsystemic sclerosis

Autor:innen und Institutionen

  • Center of Excellence in Rheumatic and Musculoskeletal Disorders, Mexico City 03530, Mexico.
  • Division of Rheumatology, Instituto Nacional de Rehabilitacion Luis Guillermo Ibarra Ibarra, Mexico City 03530, Mexico.
  • Pneumology Department, Unidad Medica de Alta Especialidad, 1 Bajio, Leon 37680, Mexico.

ORCID-Profile: Denise Clavijo-Cornejo

Zitieren

APA

Gutierrez, M., Bertolazzi, C., Zozoaga-Velazquez, E., & Clavijo-Cornejo, D. (2024). The Value of Ultrasound for Detecting and Following Subclinical Interstitial Lung Disease in Systemic Sclerosis. Tomography. https://doi.org/10.3390/tomography10040041

Vancouver

Gutierrez M, Bertolazzi C, Zozoaga-Velazquez E, Clavijo-Cornejo D. The Value of Ultrasound for Detecting and Following Subclinical Interstitial Lung Disease in Systemic Sclerosis. Tomography. 2024. doi:10.3390/tomography10040041

BibTeX
@article{Gutierrez2024,
  author = {Gutierrez, Marwin and Bertolazzi, Chiara and Zozoaga-Velazquez, Edgar and Clavijo-Cornejo, Denise},
  title = {The Value of Ultrasound for Detecting and Following Subclinical Interstitial Lung Disease in Systemic Sclerosis},
  journal = {Tomography},
  year = {2024},
  doi = {10.3390/tomography10040041}
}
Kostenlos starten →